Adenine nucleotide translocator (ANT)

The adenine nucleotide translocator (ANT) is a mitochondrial inner membrane transporter responsible for the exchange of ATP (out of the mitochondrial matrix) and ADP (into the matrix), thereby powering cellular energy-consuming processes. ANT is among the most abundant mitochondrial proteins and is essential for cellular energy metabolism. Four human isoforms exist (ANT1–4), each with distinct tissue expression profiles. In addition to its primary role in bioenergetics, ANT is a critical regulatory and structural component of the mitochondrial permeability transition pore (mPTP), involved in apoptosis and cell death pathways. ANT function and assembly are modulated by interactions with other mitochondrial proteins (e.g., voltage-dependent anion channel, cyclophilin D, Bcl-2 family), and its activity can be inhibited by specific toxins (carboxyatractyloside, bongkrekic acid, atractyloside), which are used widely in biochemical research. Dysfunction or altered expression of ANT has been implicated in a broad range of pathologies, including cardiovascular and neurodegenerative diseases, muscular dystrophies, and cancer. ANT is a therapeutic target primarily in the context of mitochondrial and metabolic diseases, although clinical applications remain experimental due to the risk of indiscriminate cell death and bioenergetic crisis upon inhibition.

Other names

ADP/ATP translocaseATP/ADP carrierANT1ANT2ANT3ANT4Solute Carrier Family 25 Member 4 (SLC25A4)AAC

CATR, ATR: Bind to cytosolic side, lock ANT in cytosolic (c-state), block ADP/ATP exchange. BKA: Binds to matrix side, locks ANT in matrix conformation (m-state), blocks exchange. Some mechanisms indirectly target apoptotic regulation via mitochondrial permeability transition pore.